OKYO Pharma LimitedOKYO Pharma LimitedOKYO Pharma Limited

OKYO Pharma Limited

No trades
Buy OKYO
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪39.48 M‬USD
‪−16.83 M‬USD
‪24.54 M‬
Beta (1Y)
1.47

About OKYO Pharma Limited


CEO
Gary S. Jacob
Headquarters
London
Founded
2007
ISIN
GG00BMFG5F62
FIGI
BBG015TS35V5
OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.